Adagio Medical (NASDAQ:ADGM) & Sysmex (OTCMKTS:SSMXY) Financial Comparison

Sysmex (OTCMKTS:SSMXY – Get Free Report) and Adagio Medical (NASDAQ:ADGM – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

Institutional & Insider Ownership

48.1% of Adagio Medical shares are owned by institutional investors. 8.9% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Sysmex and Adagio Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sysmex 6.38% 6.81% 4.72%
Adagio Medical N/A -661.85% -73.35%

Valuation and Earnings

This table compares Sysmex and Adagio Medical”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sysmex $3.32 billion 2.45 $234.01 million $0.36 37.17
Adagio Medical $600,000.00 71.76 -$25.08 million ($44.44) -0.03

Sysmex has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Sysmex, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations for Sysmex and Adagio Medical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sysmex 0 2 0 0 2.00
Adagio Medical 1 1 2 0 2.25

Adagio Medical has a consensus price target of $105.00, indicating a potential upside of 6,652.41%. Given Adagio Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Sysmex.

Volatility and Risk

Sysmex has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500.

Summary

Sysmex beats Adagio Medical on 8 of the 14 factors compared between the two stocks.

About Sysmex

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis. The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.

About Adagio Medical

(Get Free Report)

Adagio Medical is a medical technology company developing catheter-based systems for treating cardiac arrhythmias. Its technology uses ultra-low-temperature cryoablation, which applies very cold temperatures to create lesions in heart tissue that can interrupt abnormal electrical signals. The company’s platform includes the vCLAS system, designed for ventricular arrhythmias such as ventricular tachycardia, and the iCLAS system, designed for atrial fibrillation. These systems are intended for use in catheter ablation procedures by cardiac electrophysiology teams.

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.